Machine Learning Classification of MRI Features of Alzheimer's Disease and Mild Cognitive Impairment Subjects to Reduce the Sample Size in Clinical Trials

Alzheimer's Dis Neuroimaging Initi, Javier Escudero*, John P. Zajicek, Emmanuel Ifeachor

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

There is a need for objective tools to help clinicians to diagnose Alzheimer's Disease (AD) early and accurately and to conduct Clinical Trials (CTs) with fewer patients. Magnetic Resonance Imaging (MRI) is a promising AD biomarker but no single MRI feature is optimal for all disease stages. Machine Learning classification can address these challenges. In this study, we have investigated the classification of MRI features from AD, Mild Cognitive Impairment (MCI), and control subjects from ADNI with four techniques. The highest accuracy rates for the classification of controls against ADs and MCIs were 89.2% and 72.7%, respectively. Moreover, we used the classifiers to select AD and MCI subjects who are most likely to decline for inclusion in hypothetical CTs. Using the hippocampal volume as an outcome measure, we found that the required group sizes for the CTs were reduced from 197 to 117 AD patients and from 366 to 215 MCI subjects.

Original languageEnglish
Title of host publication2011 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC)
Place of PublicationNEW YORK
PublisherInstitute of Electrical and Electronics Engineers (IEEE)
Pages7957-7960
Number of pages4
ISBN (Print)978-1-4244-4122-8
Publication statusPublished - 2011
Event33rd Annual International Conference of the IEEE Engineering-in-Medicine-and-Biology-Society (EMBS) - Boston, Morocco
Duration: 30 Aug 20113 Sep 2011

Conference

Conference33rd Annual International Conference of the IEEE Engineering-in-Medicine-and-Biology-Society (EMBS)
Country/TerritoryMorocco
Period30/08/113/09/11

Keywords

  • MODEL

Fingerprint

Dive into the research topics of 'Machine Learning Classification of MRI Features of Alzheimer's Disease and Mild Cognitive Impairment Subjects to Reduce the Sample Size in Clinical Trials'. Together they form a unique fingerprint.

Cite this